Literature DB >> 22613314

Injecting patent blue dye V for sentinel lymph node biopsy without skin staining.

S Johnson1, S Arora, E Babu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22613314      PMCID: PMC3957515          DOI: 10.1308/rcsann.2012.94.4.277a

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.951


× No keyword cloud information.

BACKGROUND

Sentinel lymph node biopsy has become the gold standard technique for staging and avoidance of unnecessary node dissection in breast cancer. Combinations of blue dye and radioisotope techniques are used to identify the sentinel node. Although accuracy rates are 90- 100%, injection of blue dye can result in unwanted skin discolouration for up to 18 months. Although not pathological per se, this can cause ongoing emotional distress to women, serving as a constant reminder of the disease. We describe a simple technique of injecting patent blue dye V so as to minimise skin staining.

TECHNIQUE

An adhesive plastic film is laid over the injection site to protect the surrounding skin from any spillage of dye. The dye is then injected subdermally with a 23G needle (Fig 1) and the needle is subsequently withdrawn. Gauze is used to apply 10 seconds of pressure to the injection site to minimise immediate spillage. The plastic film is removed; it will often show minor spillage but this remains on the film as opposed to the patient’s skin.
Figure 1

Injection of blue dye with plastic film overlying skin

Injection of blue dye with plastic film overlying skin

DISCUSSION

Injecting blue dye with this technique has been used successfully by us with minimal skin staining in over 100 patients. With sentinel node biopsy being increasingly performed to prevent morbidity associated with axillary clearance, the potential application of this technique is likely to rise. We hope it will help reduce the number of women with long-term skin staining and thus decrease the psychological consequences of an otherwise very stressful and emotional procedure.
  3 in total

1.  Prolonged skin staining after intradermal use of patent blue in sentinel lymph node biopsy for breast cancer.

Authors:  G A M Govaert; R J Oostenbroek; P W Plaisier
Journal:  Eur J Surg Oncol       Date:  2005-01-20       Impact factor: 4.424

Review 2.  Sentinel node biopsy for breast cancer: technical aspects and controversies.

Authors:  Kazuyoshi Motomura; Chiyomi Egawa; Yoshifumi Komoike; Tatsuki Kataoka; Sachiko Nagumo; Hiroki Koyama; Hideo Inaji
Journal:  Breast Cancer       Date:  2007       Impact factor: 4.239

Review 3.  Clinical practice guidelines for the use of axillary sentinel lymph node biopsy in carcinoma of the breast: current update.

Authors:  Gordon F Schwartz
Journal:  Breast J       Date:  2004 Mar-Apr       Impact factor: 2.431

  3 in total
  1 in total

1.  Freehand SPECT for image-guided sentinel lymph node biopsy in breast cancer.

Authors:  Christina Bluemel; Andreas Schnelzer; Asli Okur; Alexandra Ehlerding; Stefan Paepke; Klemens Scheidhauer; Marion Kiechle
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-11       Impact factor: 9.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.